The rapid and early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is key to control the current Coronavirus disease 2019 (COVID-19) pandemic. The present study was conducted to clinically evaluate a rapid diagnostic test (RDT) kit, Standard Q COVID-19 Ag Test (SD Biosensor®, Republic of Korea), with reference to the standard real-time RT-PCR for detection of COVID-19 cases in Bangladesh. Nasopharyngeal swabs were taken from 900 COVID-19 suspected patients. Among them, 34.11% (n = 307) were diagnosed as COVID-19 cases by RT-PCR assay, of which 85% (n = 261) were also detectable using the RDT. The overall sensitivity and specificity of the RDT compared to RT-PCR were 85.02% and 100%, respectively, regardless of age, sex, and type of SARS-CoV-2 variants. Most of the RT-PCR positive cases (94%) were found within the first five days of disease onset, and the sensitivity of RDT was 85.91% for the same samples. The positive predictive value (PPV) of the RDT was 100%, and the negative predictive value (NPV) was 92.8%. The Cohen's kappa value of 0.882 indicated excellent agreement between the RDT and RT-PCR assays. The findings of this study showed the potential use of SARS-CoV-2 antigen-based RDT to expedite the diagnostic process and onward COVID-19 management in Bangladesh.
To date, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 80 million people globally. We report a case series of five clinically and laboratory confirmed COVID-19 patients from Bangladesh who suffered a second episode of COVID-19 illness after 70 symptom-free days. The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), is a leading public health research institution in South Asia. icddr, b staff were actively tested, treated and followed-up for COVID-19 by an experienced team of clinicians, epidemiologists, and virologists. From 21 March to 30 September 2020, 1370 icddr,b employees working at either the Dhaka (urban) or Matlab (rural) clinical sites were tested for COVID-19. In total, 522 (38%) were positive; 38% from urban Dhaka (483/1261) and 36% from the rural clinical site Matlab (39/109). Five patients (60% male with a mean age of 41 years) had real-time reverse transcription-polymerase chain reaction (rRT-PCR) diagnosed recurrence (reinfection) of SARS-CoV-2. All had mild symptoms except for one who was hospitalized. Though all cases reported fair risk perceptions towards COVID-19, all had potential exposure sources for reinfection. After a second course of treatment and home isolation, all patients fully recovered. Our findings suggest the need for COVID-19 vaccination and continuing other preventive measures to further mitigate the pandemic. An optimal post-recovery follow-up strategy to allow the safe return of COVID-19 patients to the workforce may be considered.
Nipah virus (NiV) is a zoonotic pathogen causing severe respiratory and neurological disease in humans, with high fatality rates, primarily transmitted from fruit bats to humans through bat-tainted raw date palm sap and fruits. NiV outbreaks have occurred almost annually across 34 of 64 districts in Bangladesh. The study investigated the geodispersal patterns and evolutionary phylodynamics of NiV, aiding in more effective outbreak management strategies in Bangladesh. Phylodynamic and geographic evolutionary analyses were conducted using the nucleoprotein (N) gene sequence ( n = 23) isolated from human and bat samples (2016–2023), along with publicly available NiV genomes up through November 2024. Bayesian evolutionary analysis of NiV spatiotemporal data suggested NiV clade expansion and the emergence of a new lineage, possibly driven by genetic mutations over time, and identified potential risk areas for NiV infections. The analysis revealed that Bangladeshi NiV strains diverged into two major lineages, BD-1 and BD-2, around 1984. BD-1 is split into NiV-BD1.1 and BD1.2 (first detected in 2004), while BD-2 emerged in 2008, later diverging into BD2.1 and BD2.2. As of 2023, most bat-derived NiV sequences belong to the BD-2 lineage. The estimated evolutionary rate of NiV in Bangladesh is 4.89 × 10⁻⁴ substitutions/site/year (95% HPD: 3.71 × 10⁻⁴ – 6.45 × 10⁻⁴), with genetic clusters spanning from 6.54 km to 116.09 km. Our findings highlight ongoing evolution, the emergence of sub-lineages, and the geographic expansion of NiV in Bangladesh, underscoring the value of phylogeographic approaches in guiding targeted surveillance and control strategies. IMPORTANCE: A comprehensive understanding of the spread and evolution of the Nipah virus is critical, as it causes severe disease and frequent outbreaks in Bangladesh. This study provides a detailed look into how different strains of the Nipah virus have geographically moved and genetically changed over nearly two decades. By analyzing virus samples from fruit bats and infected human cases, the study reveals that the virus has formed two distinct sub-lineages, evolving separately at different times and regions of Bangladesh. Identifying these groups helps pinpoint areas most at risk for future outbreaks. These insights are important for identifying high-risk regions and informing surveillance priorities for early detection and preparedness, particularly in areas with recurring spillover events. Ultimately, this research emphasizes the importance of continuously monitoring Nipah virus evolution in both bats and humans, guiding public health strategies to manage and reduce the impact of this dangerous disease in Bangladesh and other regions.
Background: The frequent detection of norovirus in the stool of healthy people may be due to prolonged norovirus shedding after recovery from illness or asymptomatic infections. We describe norovirus shedding patterns in symptomatic and asymptomatic persons in Bangladesh. Method: We enrolled acute gastroenteritis (AGE) cases and non-AGE controls from 2 hospitals from January to September, 2023. Fecal samples were tested for norovirus by rapid antigen testing and confirmed by real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Positive persons were retested at days 20, 40, 60, and 120 by RT-qPCR. Shedding duration was calculated as the number of days from enrollment to the midpoint between the last norovirus-positive and first norovirus-negative specimens. Cycle threshold (Ct) values served as an inverse proxy for the viral load. Results: Among 16 persons confirmed infected with norovirus (11/32 AGE cases; 5/28 non-AGE controls), a total of 74 stool samples were collected from enrollment through follow-up, of which 28 (38%) were norovirus positive. Of these, 20 (71%) were typed as GII.4 Sydney[P16], 1 as GII.3[P16], and 7 as GII untypeable. The median duration of norovirus shedding was similar between AGE cases (10 days, interquartile range [IQR], 9.5–29 days) and asymptomatic controls (9.5 days, IQR, 9.5–49 days). Norovirus Ct values varied substantially between persons and overlapped significantly among AGE cases and non-AGE controls. Conclusions: Norovirus shedding quantity and duration were similar between AGE cases and asymptomatic controls, complicating the attribution of norovirus infection to AGE in Bangladesh. Larger longitudinal studies would more accurately characterize norovirus shedding in resource-limited settings.